(PHG) Koninklijke Philips - Ratings and Ratios
Exchange: NYSE • Country: Netherlands • Currency: USD • Type: Common Stock • ISIN: US5004723038
PHG: Medical Imaging, Patient Monitoring, Personal Care, Mother & Baby
Koninklijke Philips N.V. (NYSE:PHG) is a global health technology leader headquartered in Amsterdam, the Netherlands, with operations spanning North America, Greater China, and other international markets. The company operates through three primary segments: Diagnosis & Treatment, Connected Care, and Personal Health. Its Diagnosis & Treatment segment offers advanced diagnostic imaging solutions, including magnetic resonance imaging (MRI), X-ray systems, computed tomography (CT) systems, and ultrasound imaging solutions. These technologies are used for diagnosis, treatment planning, and guidance across cardiac, general imaging, obstetrics/gynecology, and point-of-care applications. The segment also provides integrated interventional X-ray systems and software solutions for minimally invasive procedures in coronary, peripheral vascular, and heart rhythm management. The Connected Care segment focuses on acute patient management, emergency care, and ambulatory and home care solutions, including sleep and respiratory care. Additionally, the company offers vendor-agnostic software solutions for healthcare providers. The Personal Health segment includes a range of consumer health products, such as power toothbrushes, oral care accessories, infant feeding solutions, baby monitors, and grooming and beauty products. Philips has a long history dating back to 1891 and has evolved from a diversified electronics company to a focused health technology firm, completing its transformation in 2013.
From a financial perspective, Koninklijke Philips N.V. has a market capitalization of approximately $25.38 billion, with a forward P/E ratio of 10.63 and a price-to-book ratio of 1.53. The companys return on equity (RoE) is currently negative at -5.85%, reflecting recent financial challenges. The stock is trading at $23.29, below its 20-day, 50-day, and 200-day moving averages of $24.01, $25.65, and $27.45, respectively. The average true range (ATR) of 0.76 indicates relatively low volatility in recent trading.
Additional Sources for PHG Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PHG Stock Overview
Market Cap in USD | 23,153m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 1987-12-30 |
PHG Stock Ratings
Growth Rating | -37.1 |
Fundamental | -13.4 |
Dividend Rating | 26.8 |
Rel. Strength | -2.92 |
Analysts | 4/5 |
Fair Price Momentum | 23.47 USD |
Fair Price DCF | 27.21 USD |
PHG Dividends
Dividend Yield 12m | 3.42% |
Yield on Cost 5y | 2.49% |
Annual Growth 5y | 0.99% |
Payout Consistency | 71.7% |
PHG Growth Ratios
Growth Correlation 3m | -82.3% |
Growth Correlation 12m | -34% |
Growth Correlation 5y | -56.2% |
CAGR 5y | -6.54% |
CAGR/Max DD 5y | -0.08 |
Sharpe Ratio 12m | 0.41 |
Alpha | -12.41 |
Beta | 0.906 |
Volatility | 41.70% |
Current Volume | 905.6k |
Average Volume 20d | 769.4k |
As of May 01, 2025, the stock is trading at USD 25.35 with a total of 905,606 shares traded.
Over the past week, the price has changed by +3.64%, over one month by -0.20%, over three months by -8.09% and over the past year by -1.26%.
Neither. Based on ValueRay Fundamental Analyses, Koninklijke Philips is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -13.40 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHG as of May 2025 is 23.47. This means that PHG is currently overvalued and has a potential downside of -7.42%.
Koninklijke Philips has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy PHG.
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, PHG Koninklijke Philips will be worth about 25.5 in May 2026. The stock is currently trading at 25.35. This means that the stock has a potential upside of +0.51%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 32.7 | 28.9% |
Analysts Target Price | 32.7 | 28.9% |
ValueRay Target Price | 25.5 | 0.5% |